Hepion Pharmaceuticals, Inc.
HEPA
$0.08
$0.0115.94%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.32M | 2.92M | 4.59M | 406.40K | 1.50M |
| Total Receivables | -- | -- | -- | -- | 600.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.42M | 1.58M | 1.73M | 1.21M | 1.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.74M | 4.51M | 6.32M | 1.61M | 3.53M |
|
|
|||||
| Total Current Assets | 3.74M | 4.51M | 6.32M | 1.61M | 3.53M |
| Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 118.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 66.50K |
| Total Assets | 3.74M | 4.51M | 6.32M | 1.61M | 3.72M |
|
|
|||||
| Total Accounts Payable | 77.20K | 172.70K | 243.30K | 220.20K | 186.30K |
| Total Accrued Expenses | 55.90K | 48.50K | 166.50K | 23.70K | 306.00K |
| Short-term Debt | 214.30K | 371.70K | 526.20K | 2.90M | 2.11M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 118.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 347.40K | 592.90K | 935.90K | 3.14M | 2.72M |
|
|
|||||
| Total Current Liabilities | 347.40K | 592.90K | 935.90K | 3.14M | 2.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 214.30K | 371.70K | 526.20K | 2.90M | 2.11M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 68.40K | 115.70K | 1.49M | 333.20K | 1.41M |
| Total Liabilities | 415.80K | 708.50K | 2.42M | 3.48M | 4.12M |
|
|
|||||
| Common Stock & APIC | 247.06M | 247.06M | 246.12M | 234.25M | 234.22M |
| Retained Earnings | -245.44M | -244.97M | -243.93M | -237.82M | -236.27M |
| Treasury Stock & Other | 8.30K | 8.30K | 8.30K | 8.30K | -53.80K |
| Total Common Equity | 1.63M | 2.10M | 2.20M | -3.56M | -2.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
|
|
|||||
| Total Common Equity | 1.63M | 2.10M | 2.20M | -3.56M | -2.10M |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.32M | 3.80M | 3.90M | -1.86M | -406.70K |
|
|
|||||